Alpha 2.0
Login Register
» Articles » PMID: 8792601

Intravenous Regional Anesthesia with Ketorolac-lidocaine for the Management of Sympathetically-mediated Pain

Overview
Journal Yale J Biol Med
Specialty Biology
Date 1995 May 1
PMID 8792601
Citations 6
Authors
N R Connelly
S Reuben
S J Brull
Affiliations
Soon will be listed here.
Abstract

This retrospective study was undertaken to determine the usefulness of intravenous regional anesthetic (IVRA) blocks containing ketorolac and lidocaine in the management of sympathetically-mediated pain, and to determine what factors, if any, predicted success with this technique. Sixty-one patients with reflex sympathetic dystrophy presenting to a university-affiliated teaching hospital's pain management center were evaluated. Patients underwent one or more treatments with IVRA blocks containing ketorolac and lidocaine. The duration of pain, site of extremity affected, pain symptomatology, duration of relief from the first IVRA block, absence of pain following a series of IVRA blocks and side-effects from the IVRA blocks were determined. Of the 61 patients, 16 had complete response (26 percent), 26 had a partial response (43 percent) and 19 had no response (31 percent) to the ketorolac-containing IVRA. The only symptom which predicted a failure with this therapy was allodynia. No patient had serious side effects from the IVRA block; dizziness following tourniquet release occurred in 41 percent (n = 25) of the patients. IVRA block containing ketorolac is a useful and minimally invasive technique for the management of patients with reflex sympathetic dystrophy.

Citing Articles

Interventional Treatment of Complex Regional Pain Syndrome.

Ghaly L, Bargnes V, Rahman S, Tawfik G, Bergese S, Caldwell W Biomedicines. 2023; 11(8).

PMID: 37626759 PMC: 10452500. DOI: 10.3390/biomedicines11082263.

Analgesic effect of ketorolac added to lidocaine in surgery of traumatic arm injuries: A double-blind, randomized clinical trial.

Amini A, Farbod A, Eghbal M, Ghadimi M, Shahriyari E Eur J Transl Myol. 2022; 32(4).

PMID: 36373375 PMC: 9830390. DOI: 10.4081/ejtm.2022.10836.

The effectiveness and cost evaluation of pain exposure physical therapy and conventional therapy in patients with complex regional pain syndrome type 1. Rationale and design of a randomized controlled trial.

Barnhoorn K, Oostendorp R, van Dongen R, Klomp F, Samwel H, van der Wilt G BMC Musculoskelet Disord. 2012; 13:58.

PMID: 22515496 PMC: 3476981. DOI: 10.1186/1471-2474-13-58.

Evidence based guidelines for complex regional pain syndrome type 1.

Perez R, Zollinger P, Dijkstra P, Thomassen-Hilgersom I, Zuurmond W, Rosenbrand K BMC Neurol. 2010; 10:20.

PMID: 20356382 PMC: 2861029. DOI: 10.1186/1471-2377-10-20.

[Drug therapy in complex regional pain syndrome type I].

von Eisenhart-Rothe R, Rittmeister M Orthopade. 2004; 33(7):796-803.

PMID: 15150686 DOI: 10.1007/s00132-004-0674-8.

References
1.
MCKAIN C, Urban B, Goldner J . The effects of intravenous regional guanethidine and reserpine. A controlled study. J Bone Joint Surg Am. 1983; 65(6):808-11. View
2.
Holland A, Davies K, Wallace D . Sympathetic blockade of isolated limbs by intravenous guanethidine. Can Anaesth Soc J. 1977; 24(5):597-602. DOI: 10.1007/BF03005533. View
3.
Poplawski Z, Wiley A, Murray J . Post-traumatic dystrophy of the extremities. J Bone Joint Surg Am. 1983; 65(5):642-55. View
4.
Tountas A, Noguchi A . Treatment of posttraumatic reflex sympathetic dystrophy syndrome (RSDS) with intravenous blocks of a mixture of corticosteroid and lidocaine: a retrospective review of 17 consecutive cases. J Orthop Trauma. 1991; 5(4):412-9. View
5.
Vanos D, Ramamurthy S, Hoffman J . Intravenous regional block using ketorolac: preliminary results in the treatment of reflex sympathetic dystrophy. Anesth Analg. 1992; 74(1):139-41. DOI: 10.1213/00000539-199201000-00023. View